Compound ID | 1254
Class: PolC inhibitor (thiadiazole urea derived)
Spectrum of activity: | Gram-positive & Gram-negative |
Details of activity: | Gram-positive antibacterial drug. |
Institute where first reported: | Crestone, Inc., Boulder, United States, Colorado State University, Fort Collins, United States, SJ Brickner Consulting LLC, Ledyard, United States |
Year first mentioned: | 2019 |
Highest developmental phase: | Preclinical |
Development status: | Active |